Stereospecificity of aminoglycoside-ribosomal interactions

Biochemistry. 2002 Aug 20;41(33):10499-509. doi: 10.1021/bi026086l.

Abstract

Aminoglycoside antibiotics bind to the A-site decoding region of bacterial rRNA causing mistranslation and/or premature message termination. Aminoglycoside binding to A-site RNA decoding region constructs is established here to be only weakly stereospecific. Mirror-image prokaryotic A-site decoding region constructs were prepared in the natural D-series and the enantiomeric L-series and tested for binding to a series of aminoglycosides. In general, aminoglycosides bind to the D-series decoding region constructs with 2-3-fold higher affinities than they bind to the enantiomeric L-series. Moreover, L-neamine, the enantiomer of naturally occurring D-neamine, was prepared and shown to bind approximately 2-fold more weakly than D-neamine to the natural series decoding region construct, a result consistent with weakly stereospecific binding. The binding of naturally occurring D-neamine and its synthetic L-enantiomer was further evaluated with respect to binding to prokaryotic and eukaryotic ribosomes. Here, weak stereospecifcity was again observed with L-neamine being the more potent binder by a factor of approximately 2. However, on a functional level, unnatural L-neamine proved to inhibit in vitro translation with significantly lower potency (approximately 5-fold) than D-neamine. In addition, both L- and D-neamine are bacteriocidal toward Gram-(-) bacteria. L-Neamine inhibits the growth of E. coli and P. aeruginosa with 8- and 3-fold higher MIC than D-neamine. Interestingly, L-neamine also inhibits the growth of aminoglycoside-resistant E. coli, which expresses a kinase able to phosphorylate and detoxify aminoglycosides of the D-series. These observations suggest that mirror-image aminoglycosides may avoid certain forms of enzyme-mediated resistance.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Binding, Competitive
  • Fluorescence Polarization / methods
  • Framycetin / chemistry
  • Framycetin / pharmacology
  • Inhibitory Concentration 50
  • Microbial Sensitivity Tests
  • Oligoribonucleotides / chemical synthesis
  • Paromomycin / chemistry
  • Protein Biosynthesis / drug effects
  • RNA, Bacterial / antagonists & inhibitors
  • RNA, Bacterial / chemical synthesis
  • RNA, Bacterial / chemistry
  • RNA, Fungal / antagonists & inhibitors
  • RNA, Fungal / chemical synthesis
  • RNA, Fungal / chemistry
  • RNA, Ribosomal / antagonists & inhibitors
  • RNA, Ribosomal / chemical synthesis
  • RNA, Ribosomal / chemistry*
  • Rhodamines / metabolism
  • Ribosomes / chemistry
  • Ribosomes / drug effects
  • Spectrometry, Fluorescence
  • Stereoisomerism
  • Tobramycin / chemistry

Substances

  • 5-carboxytetramethylrhodamine
  • Anti-Bacterial Agents
  • Oligoribonucleotides
  • RNA, Bacterial
  • RNA, Fungal
  • RNA, Ribosomal
  • Rhodamines
  • Framycetin
  • Paromomycin
  • Tobramycin